ArticleGenes & diseases2026

Blockade of co-inhibitory receptor immune checkpoint protein TIM3/CD366 augments the anti-cancer activity of CAR-T therapy in solid tumors: An ovarian cancer example.

Binglan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.